Clinical trial
The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint…
NCT00279864 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00279864 |
|---|---|
| Title | The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection |
| Official title | Prolonged Oral Levofloxacin-Rifampin for Staphylococcus Aureus Prosthetic Joint Infection (PJI) Treated With Debridement And Retention Of Components: A Prospective Observational Cohort Study. Mayo PJI Study Group (MPSG)* |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Ortho-McNeil, Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Staphylococcal Infection, Staphylococcus Aureus Prosthetic Joint Infection |
| Enrollment | 15 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jan 20, 2006 |
| Last update posted | Apr 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: